InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
71%
T+90 mean return
+9.7%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by snyderman nancy lynn MD, Director. Officer active across 3 companies, notably Alkermes plc.. In total, 18 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 20 May 2021. The latest transaction was filed on 21 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations18 total
6,142 sharesOrdinary SharesSEC:0001520262-26-000091:0
1,475 shares@ US$36.950.0010% mcap83.8% of flowOrdinary SharesSEC:0001520262-26-000091:1
14,944 shares@ US$71.00100.0% of flowCommon StockSEC:0001562180-24-007710:0
5,000 shares0Common StockSEC:0001562180-24-007659:0
6,104 sharesOrdinary SharesSEC:0001127602-24-019603:0
5,957 sharesOrdinary SharesSEC:0001127602-23-020550:0
3,000 shares0Common StockSEC:0001562180-23-005532:0
2,100 shares0Common StockSEC:0001562180-22-006264:0
7,585 sharesOrdinary SharesSEC:0001127602-22-017639:0
427 shares@ US$23.430.0002% mcap100.0% of flowOrdinary SharesSEC:0001127602-22-008576:0
Ideal exit: 29 Nov 2022 (T+270)
5,578 sharesOrdinary SharesSEC:0001127602-21-030303
5,578 sharesOrdinary SharesSEC:0001127602-21-030303:0
2,261 shares0Common StockSEC:0001562180-21-006778
2,261 shares0Common StockSEC:0001562180-21-006778:0
1,688 shares0Common stock, par value $0.0001 per shareSEC:0001104659-21-129991:0
1,688 shares0Common stock, par value $0.0001 per shareSEC:0001104659-21-129991
6,104 shares0Ordinary SharesSEC:0001127602-21-017790
6,104 shares0Ordinary SharesSEC:0001127602-21-017790:0
18 of 18 declarations
About snyderman nancy lynn MD
Nancy Lynn Snyderman, MD, is a Board Member at Alkermes plc, Future Health ESG Corp., and Axonics, Inc. She provides her expertise in governance and strategy, contributing to guiding decisions and ensuring compliance. Her experience in the healthcare sector is a valuable asset to the board.
